Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Yellow Nail Syndrome

Yellow nail syndrome (YNS) is a rare disorder, in which there is a triad of:

  • Nail discolouration and nail dystrophy
  • Lymphoedema
  • Pleural effusions1 (alternatively, 'chronic respiratory problems' is used by some authors in the definition2)

Other associated features have also been reported. It was first described by Samman in 1964.3

Epidemiology4

It is very rare, with around 100 published cases.

Aetiology
  • Both familial and sporadic cases have been reported.
  • YNS has been classified as a dominantly inherited lymphoedema with variable expression. However,this classification and aetiology have been disputed, suggesting it may not be a genetic disease.2,5
  • The cause and underlying pathogenesis of the nail changes is uncertain.6
  • The cause of lymphoedema is unknown, but it may be functional or secondary lymphatic disorder rather than a primary one.7
Clinical features
  • Age of onset varies, and has been reported from antenatal to 65 years.
  • The different clinical features of the syndrome may occur at wide intervals. Patients may not present with the the classical triad of symptoms.1

Nail features1,4

  • Typically the nails are slow-growing with a yellowish discoloration.5
  • Various other nail changes have been described, including onycholysis, ridging, thickening, over-curvature and absence of the lunula.

Lymphoedema

The lymphoedema can be widespread, including peripheral oedema (usually lower limb), pleural effusions and ascites.4 Facial and laryngeal oedema have also been reported.5

Respiratory disorders4,8

Various respiratory conditions may occur:

Other possible associated clinical features

The following have also been reported; note that these are case reports only, so the link to yellow nail syndrome is uncertain:

  • Chylous ascites10,11
  • Intestinal lymphangiectasia10
  • Non-immune hydrops and chylothorax in a fetus and neonate whose mothers had yellow nail syndrome5,12
  • Thyroid abnormalities1
  • Immunological abnormalities, e.g. IgA deficiency1
  • Various other conditions have also been reported in patients with YNS1,4
Assessment and diagnosis1
  • The diagnosis is made clinically, once other causes have been excluded.
  • Be aware that the different clinical features of the syndrome may occur at wide intervals.
  • The absence of nail changes does not exclude the diagnosis, if other causes of pleural effusions and lymphoedema have been excluded.
Management

There is no specific treatment for YNS. Standard treatments can be used for lymphoedema, pleural effusions and bronchiectasis. In addition, the following treatments have been reported as helpful in individual cases:

  • For nails:
    • Topical vitamin E (in dimethyl sulphoxide); both ingredients seemed helpful.13
    • Oral vitamin E.14
    • Oil applied to the nails (in this case, topical vitamin E was not beneficial).15
    • Itraconazole pulse therapy.14
    • Oral zinc supplementation.16
  • For lymphoedema: oral zinc supplementation.16
  • For pleural effusions:8
    • Medical treatment:
      • Diuretics and low fat diet are possible treatments, but may be inadequate. (A low fat diet with added medium chain triglycerides reduces the load on the lymphatics, because medium chain triglycerides are absorbed into the portal venous system, whereas long chain fatty acids are absorbed into the intestinal lymphatics).11
      • Octreotide, a somatostatin analogue, has been used successfully to treat chylous pleural effusion.17
    • Surgical treatment may be required:
      • Pleurodesis18,19 or pleurectomy.
      • Pleuroperitoneal or pleurovenous shunt.
    However, there are potential complications of surgical treatment (see below).
  • Chylous ascites:
    • In one case, this was successfully treated by a diet low in fat, with added medium-chain triglycerides (as explained above).11
    • Octreotide has been reported as beneficial.17
  • Rhinosinusitis: In one review, conventional treatments were generally unhelpful, but functional endoscopic sinus surgery seemed more useful.9
Complications8
  • Massive pleural effusions can be life-threatening.4,19
  • Surgical treatment of pleural effusions may have complications:
    • In one case, a pleuroperitoneal shunt led to severe oedema and abdominal distention.
    • Pleurodesis can lead to hypoventilation.19
  • Repeated loss of chyle from drainage of the pleural effusions can lead to malnourishment.
  • Lymphoedema can affect quality of life.
Prognosis

There is little mention of prognosis in the literature. However, a number of case reports describe patients in their sixties and seventies.1,4,8,19 The most problematic complication seems to be large, recurrent pleural effusions.

Spontaneous resolution of the nail changes has been described in some patients.2


Document references
  1. Nakielna EM, Wilson J, Ballon HS; Yellow-nail syndrome: report of three cases. Can Med Assoc J. 1976 Jul 3;115(1):46-8. [abstract]
  2. Hoque SR, Mansour S, Mortimer PS; Yellow nail syndrome: not a genetic disorder? Eleven new cases and a review of the literature. Br J Dermatol. 2007 Jun;156(6):1230-4. Epub 2007 Apr 25. [abstract]
  3. Samman PD, White WF; The "Yellow nail" syndrome. Br J Dermatol. 1964 Apr;76:153-7.
  4. Razi, E. Familial yellow nail syndrome. Dermatolgoy Online Journal 2006, 12 (2):15.
  5. OMIM - Yellow Nail Syndrome
  6. DeCoste SD, Imber MJ, Baden HP; Yellow nail syndrome. J Am Acad Dermatol. 1990 Apr;22(4):608-11. [abstract]
  7. Bull RH, Fenton DA, Mortimer PS; Lymphatic function in the yellow nail syndrome. Br J Dermatol. 1996 Feb;134(2):307-12. [abstract]
  8. Tanaka E, Matsumoto K, Shindo T, et al; Implantation of a pleurovenous shunt for massive chylothorax in a patient with yellow nail syndrome. Thorax. 2005 Mar;60(3):254-5. [abstract]
  9. Varney VA, Cumberworth V, Sudderick R, et al; Rhinitis, sinusitis and the yellow nail syndrome: a review of symptoms and response to treatment in 17 patients. Clin Otolaryngol Allied Sci. 1994 Jun;19(3):237-40. [abstract]
  10. Duhra PM, Quigley EM, Marsh MN; Chylous ascites, intestinal lymphangiectasia and the 'yellow-nail' syndrome. Gut. 1985 Nov;26(11):1266-9. [abstract]
  11. Tan WC; Dietary treatment of chylous ascites in yellow nail syndrome. Gut. 1989 Nov;30(11):1622-3. [abstract]
  12. Govaert P, Leroy JG, Pauwels R, et al; Perinatal manifestations of maternal yellow nail syndrome. Pediatrics. 1992 Jun;89(6 Pt 1):1016-8. [abstract]
  13. Williams HC, Buffham R, du Vivier A; Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome. Arch Dermatol. 1991 Jul;127(7):1023-8. [abstract]
  14. Luyten C, Andre J, Walraevens C, et al; Yellow nail syndrome and onychomycosis. Experience with itraconazole pulse therapy combined with vitamin E. Dermatology. 1996;192(4):406-8. [abstract]
  15. Lambert EM, Dziura J, Kauls L, et al; Yellow nail syndrome in three siblings: a randomized double-blind trial of topical vitamin E. Pediatr Dermatol. 2006 Jul-Aug;23(4):390-5. [abstract]
  16. Arroyo JF, Cohen ML; Improvement of yellow nail syndrome with oral zinc supplementation. Clin Exp Dermatol. 1993 Jan;18(1):62-4. [abstract]
  17. Makrilakis K, Pavlatos S, Giannikopoulos G, et al; Successful octreotide treatment of chylous pleural effusion and lymphedema in the yellow nail syndrome. Ann Intern Med. 2004 Aug 3;141(3):246-7.
  18. Jiva TM, Poe RH, Kallay MC; Pleural effusion in yellow nail syndrome: chemical pleurodesis and its outcome. Respiration. 1994;61(5):300-2. [abstract]
  19. Yamagishi T, Hatanaka N, Kamemura H, et al; Idiopathic yellow nail syndrome successfully treated with OK-432. Intern Med. 2007;46(14):1127-30. Epub 2007 Jul 17. [abstract]

Internet and further reading Acknowledgements EMIS is grateful to Dr N Hartree for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 2948
Document Version: 20
DocRef: bgp108
Last Updated: 12 May 2008
Review Date: 12 May 2010






















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page